» Articles » PMID: 16677673

Cerebellar Ataxia with Coenzyme Q10 Deficiency: Diagnosis and Follow-up After Coenzyme Q10 Supplementation

Overview
Journal J Neurol Sci
Publisher Elsevier
Specialty Neurology
Date 2006 May 9
PMID 16677673
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Our aim was to report a new case with cerebellar ataxia associated with coenzyme Q10 (CoQ) deficiency, the biochemical findings caused by this deficiency and the response to CoQ supplementation.

Patient: A 12-year-old girl presenting ataxia and cerebellar atrophy. BIOCHEMICAL STUDIES: Coenzyme Q10 in muscle was analysed by HPLC with electrochemical detection and mitochondrial respiratory chain (MRC) enzyme activities by spectrophotometric methods. CoQ biosynthesis in fibroblasts was assayed by studying the incorporation of radiolabeled 4-hydroxy[U 14C] benzoic acid by HPLC with radiometric detection.

Results: Mitochondrial respiratory chain enzyme analysis showed a decrease in complex I + III and complex II + III activities. CoQ concentration in muscle was decreased (56 nmol/g of protein: reference values: 157-488 nmol/g protein). A reduced incorporation of radiolabeled 4-hydroxy[U- 14C] benzoic acid was observed in the patient (19% of incorporation respect to the median control values). After 16 months of CoQ supplementation, the patient is now able to walk unaided and cerebellar signs have disappeared.

Conclusions: Cerebellar ataxia associated with CoQ deficiency in our case might be allocated in the transprenylation pathway or in the metabolic steps after condensation of 4-hydroxybenzoate and the prenyl side chain of CoQ. Clinical improvement after CoQ supplementation was remarkable, supporting the importance of an early diagnosis of this kind of disorders.

Citing Articles

The Spectrum of clinical manifestations in newborns with the COQ4 mutation: case series and literature review.

Pan P, Zhou N, Sun Y, Chen Z, Han J, Zhou W Front Pediatr. 2024; 12:1410133.

PMID: 39398416 PMC: 11466766. DOI: 10.3389/fped.2024.1410133.


The Ubiquinone-Ubiquinol Redox Cycle and Its Clinical Consequences: An Overview.

Mantle D, Dewsbury M, Hargreaves I Int J Mol Sci. 2024; 25(12).

PMID: 38928470 PMC: 11203502. DOI: 10.3390/ijms25126765.


Understanding coenzyme Q.

Wang Y, Lilienfeldt N, Hekimi S Physiol Rev. 2024; 104(4):1533-1610.

PMID: 38722242 PMC: 11495197. DOI: 10.1152/physrev.00040.2023.


Primary Coenzyme Q10 Deficiency-Related Ataxias.

Lopriore P, Vista M, Tessa A, Giuntini M, Caldarazzo Ienco E, Mancuso M J Clin Med. 2024; 13(8).

PMID: 38673663 PMC: 11050807. DOI: 10.3390/jcm13082391.


Mutations of GEMIN5 are associated with coenzyme Q deficiency: long-term follow-up after treatment.

Cascajo-Almenara M, Julia-Palacios N, Urreizti R, Sanchez-Cuesta A, Fernandez-Ayala D, Garcia-Diaz E Eur J Hum Genet. 2024; 32(4):426-434.

PMID: 38316953 PMC: 10999423. DOI: 10.1038/s41431-023-01526-2.